NASDAQ
Defence Therapeutics Inc. (DTCFF) has a current ratio of 0.50x as of Monday, May 25, 2026. This represents a 96.74% decrease compared to its 12-month average of 15.44x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.